Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.

Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.
复制标题

DOI:
10.1002/lary.29208
复制
发表时间:
2021-06
期刊:
The Laryngoscope
影响因子:
--
通讯作者:
Jorgensen JB
Jorgensen JB
中科院分区:
其他
文献类型:
--
作者:
Bollig CA;Newberry CI;Galloway TLI;Zitsch RP;Hanly EK;Zhu VL;Pagedar N;Nallani R;Bur AM;Spanos WC;Jorgensen JB

文献摘要

参考文献

被引文献

相似文献

在一个多机构队列中研究远端转移(DM)的部位和模式与DM头颈癌(HNC)患者总生存期(OS)之间的关系。回顾性审查。对2000年至2015年期间在中西部HNC联盟的4个学术中心接受治疗的283例患者进行了回顾性分析。疾病模式分为单发转移性与多发转移性(≥2个部位)疾病。使用Kaplan-Meier和考克斯比例风险模型估计临床相关变量的生存函数。所有患者的中位OS为9.0个月(95%置信区间[CI]:7.4-10.6)。肺(n = 220,77.7%)是DM最常见的部位,其次是骨(n = 90,31.8%)、纵隔淋巴结(n = 55,19.4%)、肝脏(n = 41,14.5%)和脑(n = 17,6.0%)。骨转移与最差预后独立相关(风险比[HR] = 1.6,95% CI:1.3-2.1)。在单变量分析中,脑转移与预后改善相关(HR = 0.5,95%CI:0.3-0.9),尽管在多变量分析中没有统计学意义。大多数患者(n = 230,81.3%)存在多转移性疾病,与孤立性转移性疾病相比,预后较差(HR = 1.4,95% CI:1.0-2.0)。我们的大型多机构综述表明,DM的转移模式和部位均影响OS。多发性转移性疾病和骨转移与预后不良相关,与接受的治疗无关。
Investigate the relationship between site and pattern of distant metastasis (DM) and overall survival (OS) in a multi-institutional cohort of patients with DM head and neck cancer (HNC). Retrospective review. 283 patients treated at 4 academic centers in the Midwest HNC Consortium between 2000 and 2015 were retrospectively reviewed. Disease patterns were divided between solitary metastatic versus polymetastatic (≥2 sites) disease. Survival functions for clinically relevant variables were estimated using Kaplan-Meier and Cox proportional hazards models. Median OS for all patients was 9.0 months (95% confidence interval [CI]: 7.4–10.6). Lung (n = 220, 77.7%) was the most common site of DM, followed by bone (n = 90, 31.8%), mediastinal lymph nodes (n = 55, 19.4%), liver (n = 41, 14.5%), and brain (n = 17, 6.0%). Bone metastases were independently associated with the worst prognosis (hazard ratio [HR] = 1.6, 95% CI: 1.3–2.1). On univariate analysis, brain metastases were associated with improved prognosis (HR = 0.5, 95% CI: 0.3–0.9), although this was not statistically significant on the multivariate analysis. Polymetastatic disease was present in the majority of patients (n = 230, 81.3%) and was associated with a worse prognosis compared to solitary metastatic disease (HR = 1.4, 95% CI: 1.0–2.0). Our large, multi-institutional review indicates that both the metastatic pattern and site of DM impact OS. Polymetastatic disease and bone metastasis are associated with worse prognosis, independent of treatment received.
DOI: 10.1080/0284186x.2018.1487581
发表时间: 2018-11-02
期刊: ACTA ONCOLOGICA
影响因子: 3.1
作者:
Prasanna, Thiru;Karapetis, Christos S.;Yip, Desmond
通讯作者: Yip, Desmond
DOI: 10.1177/0194599815581836
发表时间: 2015-08-01
影响因子: 3.4
作者:
Jaber, James J.;Murrill, Lauren;Mehta, Vikas
通讯作者: Mehta, Vikas
DOI: 10.1016/j.oraloncology.2005.01.012
发表时间: 2005-05-01
期刊: ORAL ONCOLOGY
影响因子: 4.8
作者:
Kowalski, LP;Carvalho, AL;Magrin, J
通讯作者: Magrin, J
DOI: 10.1038/s41416-019-0601-8
发表时间: 2019-11-26
影响因子: 8.8
作者:
Beckham, Thomas H.;Leeman, Jonathan E.;Tsai, C. Jillian
通讯作者: Tsai, C. Jillian
DOI: 10.1007/s10549-015-3341-3
发表时间: 2015-04-01
影响因子: 3.8
作者:
Kast, Karin;Link, Theresa;Wimberger, Pauline
通讯作者: Wimberger, Pauline